(Q40968139)

25 September 2017

1 reference

title

Antisense oligodeoxynucleotides as clinical therapeutic agents (English)

1 reference

25 September 2017

Tonkinson JL

1

1 reference

25 September 2017

Stein CA

series ordinal

2

1 reference

25 September 2017

publication date

1 January 1996

1 reference

25 September 2017

1 reference

25 September 2017

volume

14

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

54-65

1 reference

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense inhibition of ras p21 expression that is sensitive to a point mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Physicochemical properties of phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Inhibition of hormone-stimulated steroidogenesis in cultured Leydig tumor cells by a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to diazepam-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Characterization of oligonucleotide transport into living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Characteristics of oligonucleotide uptake in human keratinocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Receptor-mediated transport of oligodeoxynucleotides into hepatic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antiproliferative effects of antisense oligonucleotides directed to the RNA ofc-myconcogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Oligodeoxynucleotide-based therapeutics for human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Modulation of P-glycoprotein-mediated multidrug resistance by monoclonal antibodies, immunotoxins or antisense oligodeoxynucleotides in kidney carcinoma and normal kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

PKC epsilon is involved in granulocyte-macrophage colony-stimulating factor signal transduction: evidence from microphysiometry and antisense oligonucleotide experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Autoinduction of platelet derived growth factor (PDGF) A-chain mRNA expression in a human malignant melanoma cell line and growth inhibitory effects of PDGF-A-chain mRNA-specific antisense molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Role of epidermal growth factor expression in early mouse embryo lung branching morphogenesis in culture: antisense oligodeoxynucleotide inhibitory strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Quantitative hybridization-arrest of mRNA in Xenopus oocytes using single-stranded complementary DNA or oligonucleotide probes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Specific inhibition of lymphokine biosynthesis and autocrine growth using antisense oligonucleotides in Th1 and Th2 helper T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) line.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Antisense oligodeoxynucleotides to GS protein alpha-subunit sequence accelerate differentiation of fibroblasts to adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Attenuation of microtubule-associated protein 1B expression by antisense oligodeoxynucleotides inhibits initiation of neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/07357909609018436

10.3109/07357909609018436

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference